Search for 'an:"1906" and au:Cuezva, J.M. and itype:ART'

Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors.

By Cuezva, J.M. | Sánchez Aragó, María. Antioxidants & redox signaling, 2013 . 19(3):285-98. , Formato Vancouver: Sánchez-Aragó M, Formentini L, Cuezva JM. Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors. Antioxid Redox Signal. 2013 Jul 20;19(3):285-98.

Place Hold on Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors.

Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.

By Aldea, M. | Cuezva, J.M. | Sánchez Aragó, María. Oncogenesis, 2013 . 2:e46. , Formato Vancouver: Sánchez-Aragó M, Formentini L, Martínez-Reyes I, García-Bermudez J, Santacatterina F, Sánchez-Cenizo L et al. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis. 2013 Apr 22;2:e46.

Place Hold on Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.

Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells.

By Cuezva, J.M. | Sánchez Aragó, María. EMBO reports, 2013 . 14(7):638-44. , Formato Vancouver: Sánchez-Aragó M, García-Bermúdez J, Martínez-Reyes I, Santacatterina F, Cuezva JM. Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells. EMBO Rep. 2013 Jul;14(7):638-44.

Place Hold on Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells.

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer.

By Cuezva, J.M. | Sánchez Aragó, María. Cell cycle (Georgetown, Tex.), 2012 . 11(16):2963-4. , Formato Vancouver: Sánchez-Aragó M, Formentini L, García-Bermúdez J, Cuezva JM. IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer. Cell Cycle. 2012 Aug 15;11(16):2963-4.

Place Hold on IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer.

The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil

By Cuezva, J.M. | Sánchez Aragó, María. Journal of Translational Medicine, 2011 . 9:19. , Formato Vancouver: Sánchez Aragó M, Cuezva JM. The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil. J Transl Med. 2011;9:19.

Place Hold on The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil

Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy.

By Cuevas Martín, Carmen | Sánchez Aragó, María | Cuezva, J.M.. PLoS genetics, 2015 . 11(4):e1005115. , Formato Vancouver: Barneo Muñoz M, Juárez P, Civera Tregón A, Yndriago L, Pla Martin D, Zenker J et al. Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy. PLoS Genet. 2015 Apr 10;11(4):e1005115.

Place Hold on Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy.

PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase.

By García Bermúdez, Javier | Sánchez Aragó, María | Soldevilla, Beatriz | Arco, Araceli del | Nuevo Tapioles, Cristina | Cuezva, J.M.. Cell reports, 2015 . 12(12):2143-55. , Formato Vancouver: García Bermúdez J, Sánchez Aragó M, Soldevilla B, Del Arco A, Nuevo Tapioles C, Cuezva JM. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase. Cell Rep. 2015 Sep 29;12(12):2143-55.

Place Hold on PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase.

Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases.

By Santacatterina, Fulvio | Chamorro, Margarita | Núñez de Arenas, Cristina | Martín, Miguel Ángel | Cuezva, J.M. | Sánchez Aragó, María. Journal of translational medicine, 2015 . 13:65. , Formato Vancouver: Santacatterina F, Chamorro M, de Arenas CN, Navarro C, Martín MA, Cuezva JM et al. Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases. J Transl Med. 2015 Feb 18;13:65.

Place Hold on Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases.

Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells.

By Cuezva, J.M. | Sánchez Aragó, María. Biochimica et biophysica acta, 2015 . 1853(5):1182-94. , Formato Vancouver: Linares CI, Ferrín G, Aguilar Melero P, González Rubio S, Rodríguez Perálvarez M, Sánchez Aragó M et al. Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells. Biochim Biophys Acta. 2015 May;1853(5):1182-94.

Place Hold on Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells.

Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state.

By Santacatterina, Fulvio | Sánchez Cenizo, Laura | Formentini, Laura | Casas, Estela | Martínez Reyes, Inmaculada | García Bermúdez, Javier | Sánchez Aragó, María | Satrústegui, Jorgina | Cuezva, J.M.. Oncotarget, 2016 . 7(1):490-508. , Formato Vancouver: Santacatterina F, Sánchez Cenizo L, Formentini L, Mobasher MA, Casas E, Rueda CB et al. Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state. Oncotarget. 2016 Jan 5;7(1):490-508.

Place Hold on Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state.